Literature DB >> 16798221

Intraoperative, radio-guided sentinel lymph node mapping in 110 nonsmall cell lung cancer patients.

Witold Rzyman1, Ole M Hagen, Rafal Dziadziuszko, Grazyna Kobierska-Gulida, Andrzej Karmolinski, Inger M Lothe, Almira Babovic, Maciej Murawski, Waldemar Paleczka, Tomasz Jastrzebski, Andrzej Kopacz, Jacek Jassem, Piotr Lass, Jaroslaw Skokowski.   

Abstract

BACKGROUND: Sentinel lymph node identification has been tested in lung cancer patients with conflicting results. The present study was designed to assess the sensitivity, negative predictive value, and accuracy of intraoperative sentinel lymph node mapping by means of a radio-guided method in patients with nonsmall cell lung cancer to find the most appropriate definition of sentinel lymph node and to evaluate the usefulness of different particle sizes of radiocolloid.
METHODS: One hundred ten patients with clinically N0 nonsmall cell lung cancer were enrolled in the pilot study of intraoperative sentinel node identification. Four quadrants of the peritumoral tissue were injected with 2 mL of 0.5 mCi technetium-99m suspension. Four radiocolloids of different particle size were used. After complete lymphadenectomy, all resected lymph nodes were examined with hematoxylin-eosin staining. All sentinel nodes negative for metastases by routine staining were searched further for metastatic deposits with both serial sections and immunohistochemistry for cytokeratins.
RESULTS: The radio-guided method had a high identification rate, a high sensitivity, and a high negative predictive value (100%, 87%, and 93%, respectively) when immunohistochemistry was considered. When standard hematoxylin and eosin staining was applied, sensitivity and negative predictive value of sentinel lymph node labeling was lower (74% and 89%, respectively). No significant differences were found in either the sensitivity or negative predictive value among the colloid solutions of different particle size used in radio labeling, although smaller particles have shown a tendency to produce better results.
CONCLUSIONS: The radio-guided technique provides efficient sentinel lymph node identification in lung cancer. Further studies are warranted to confirm the clinical utility of this strategy.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16798221     DOI: 10.1016/j.athoracsur.2006.01.094

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  6 in total

1.  Radioisotope-guided localization and resection of non-palpable focal lesion of the rib.

Authors:  Francesco Petrella; Giorgio Lo Iacono; Monica Casiraghi; Lorenzo Gherzi; Elena Prisciandaro; Cristiano Rampinelli; Marzia Colandrea; Chiara Maria Grana; Lorenzo Spaggiari
Journal:  J Thorac Dis       Date:  2020-01       Impact factor: 2.895

Review 2.  Current innovations in sentinel lymph node mapping for the staging and treatment of resectable lung cancer.

Authors:  Krista J Hachey; Yolonda L Colson
Journal:  Semin Thorac Cardiovasc Surg       Date:  2014-09-16

3.  Sentinel lymph node mapping in patients with operable non-small cell lung cancer.

Authors:  Yekta Altemur Karamustafaoglu; Yener Yoruk; Fazli Yanik; Ali Sarikaya
Journal:  J Thorac Dis       Date:  2013-06       Impact factor: 2.895

Review 4.  A comprehensive overview of radioguided surgery using gamma detection probe technology.

Authors:  Stephen P Povoski; Ryan L Neff; Cathy M Mojzisik; David M O'Malley; George H Hinkle; Nathan C Hall; Douglas A Murrey; Michael V Knopp; Edward W Martin
Journal:  World J Surg Oncol       Date:  2009-01-27       Impact factor: 2.754

5.  Sentinel ode apping in on-small ell ung ancer sing an ntraoperative adiotracer echnique.

Authors:  Susan Shafiei; Reza Bagheri; Ramin Sadeghi; Vahid Reza Dabbagh Kakhki; Amir Hossein Jafarian; Reza Afghani; Davood Attaran; Reza Basiri; Shahrzad M Lari
Journal:  Asia Ocean J Nucl Med Biol       Date:  2019

6.  Long-term outcomes of sentinel node identification using indocyanine green in patients with lung cancer.

Authors:  Yukikiyo Kawakami; Kazuya Kondo; Naoya Kawakita; Hisashi Matsuoka; Hiroaki Toba; Hiromitsu Takizawa; Mitsuteru Yoshida; Akira Tangoku
Journal:  Thorac Cancer       Date:  2020-11-21       Impact factor: 3.223

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.